Nanoformulation of Artemisia afra and its potential biomedical applications in type 2 diabetes

Simple item page
dc.contributor.advisorPearce, Brendon
dc.contributor.advisorBenjeddou, Mongi
dc.contributor.authorLiebenberg, Nicole Albertha-Wade
dc.date.accessioned2020-12-09T12:01:58Z
dc.date.accessioned2024-05-09T07:46:36Z
dc.date.available2020-12-09T12:01:58Z
dc.date.available2024-05-09T07:46:36Z
dc.date.issued2019
dc.description>Magister Scientiae - MScen_US
dc.description.abstractCurrent research classifies Type 2 diabetes as most prevalent non-communicable diseases in South Africa. Approximately 285 million people are affected globally with an expected increase to 595 million by the year 2035. Synthetic first-line drugs in the treatment of Type 2 diabetes, have been shown to have an efficacy rate of approximately 43% as a result of poor drug uptake and metabolism. Furthermore, given South Africa’s uniquely diverse botanical heritage, herbs commonly used traditional medicine have shown promise in the treatment of Type 2 diabetes.en_US
dc.identifier.urihttps://hdl.handle.net/10566/13429
dc.language.isoenen_US
dc.publisherUniversity of Western Capeen_US
dc.rights.holderUniversity of Western Capeen_US
dc.subjectType 2 diabetesen_US
dc.subjectArtemisia afraen_US
dc.subjectNanoparticlesen_US
dc.subjectGold nanoparticlesen_US
dc.subjectGreen chemistryen_US
dc.titleNanoformulation of Artemisia afra and its potential biomedical applications in type 2 diabetesen_US

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
liebenberg_m_nsc_2019.pdf
Size:
5.95 MB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Plain Text
Description:
Download

Collections

Magister Scientiae - MSc (Biotechnology)